|
|
|
|
Science Sparks @ ACTREC
|
 18th July 2022 |
Vol. No. 11; Issue No. 535 |
|
|
Publications
|
|
1. Dey P, Joshi M, Mujawar A, Malhotra R, De A (2022). Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordr).
2. Sitani K, Parghane R, Talole S, Basu S (2022). The efficacy, toxicity and survival of salvage retreatment PRRT with 177Lu-DOTATATE in patients with progressive NET following initial course of PRRT. British Journal of Radiology.
Book Chapter
Mujawar A, De A. (2022). In vivo assessment of protein-protein interactions using BRET assay. In: Kim SB. (Ed.) Bioluminescence. Methods in Molecular Biology, vol 2525. New York; Humana.
|
|
|
|
|
|
|
Legends of Science
|
|
Mahitosh Mandal
Mahitosh Mandal secured his Ph.D. from the Indian Institute of Chemical Biology. His main research areas include cancer therapeutics, drug delivery, therapeutic resistance, and diagnostics. Their team is evaluating several possible biomarkers and their efficacy in targeted therapy. The molecular mechanisms promoting radio and chemoresistance in cancer are being deciphered. He is an elected fellow of the National Academy of Sciences, Allahabad, and the Indian Academy of Sciences, Bengaluru. Dr. Mandal also received Basanti Devi Amir Chand Award by ICMR; Prof. S. S. Katiyar Endowment Award by the Indian Science Congress; Subha Mukherjee Memorial Award by the Physiological Society of India.
|
|
| |
|
Ashok Sadanand Kolaskar
Ashok Kolaskar obtained his Ph.D. from the Indian Institute of Science, Bengaluru, in 1976. His areas of research are bioinformatics, molecular immunology, and computational chemistry. He initiated the nucleic acid sequence data analysis in India and developed a simple but accurate method to predict protein-coding regions in prokaryotic DNA. A numerical coding system developed by him that codes complete properties is used to prepare the world's largest computerized data bank for animal viruses. He is an elected fellow of the Indian Academy of Sciences, Bengaluru, and Maharashtra Academy of Sciences. He received the PARAM award from the Centre for Development of Advanced Computing.
|
|
| |
|
|
Upcoming Events
|
| |
|
|
| |
|
|
|
|
| |
|
ComBio2022
|
|
27-30 September, 2022
|
|
At Melbourne, Australia
|
|
|
| |
|
|
Do You Know?
In 2017, The FDA approved the use of enasidenib for adult patients with relapsed or refractory acute myeloid leukemia.
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
